Gennex Laboratories

Gennex Laboratories Goodwill

Goodwill of Gennex Laboratories (531739.BO) as of Nov 16, 2026.

Goodwill

0.00INR

Last updated:

Goodwill of Gennex Laboratories is 2026 0.00 INR. Goodwill of Gennex Laboratories was 2025 0.00 INR. It decreases by % lower compared to the previous year.

The Gennex Laboratories Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2018
0.00 INR
Jan 1, 2019
0.00 INR
Jan 1, 2022
0.00 INR
Jan 1, 2024
0.00 INR
Jan 1, 2025
0.00 INR
Jan 1, 2026
0.00 INR
The Gennex Laboratories Goodwill history
YEARGoodwillYoY
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Gennex Laboratories Stock analysis

What does Gennex Laboratories do? Gennex Laboratories Ltd manufactures bulk drugs and intermediates, including active pharmaceutical ingredients like Guaifenesin USP/BP/EP/IP for expectorants, Methocarbamol USP for muscle relaxants, Phenazopyridine Hcl USP for urinary tract analgesics, Fluconazole EP/USP for anti-fungal products, Mephenesin IP/BP for muscle relaxants, Chlorphenesin IP/BP for anti-fungal, and Melitracen Hcl as an antidepressant. The company operates through the Pharmaceutical Products (Bulk Drugs) segment, serving domestic and international markets from its Indian manufacturing facilities. Its product portfolio spans expectorants, muscle relaxants, analgesics, and anti-fungals, with specific ingredients targeting respiratory, musculoskeletal, urinary, and fungal conditions. Gennex Laboratories Ltd targets pharmaceutical companies and healthcare providers globally, supplying bulk drugs and intermediates for formulation into final medicines. The firm’s manufacturing facilities in India produce active pharmaceutical ingredients under strict quality standards, including USP, BP, EP, and IP specifications. Its products serve key therapeutic segments such as respiratory care, pain management, and antifungal treatments, directly supporting drug manufacturers in developing finished pharmaceutical products for consumer markets. The company’s revenue streams derive from the sale of bulk drug ingredients to pharmaceutical manufacturers, who integrate them into their own branded products. Gennex’s portfolio includes established ingredients like Guaifenesin and Fluconazole, which are widely used in global pharmaceutical supply chains. By focusing on high-demand therapeutic areas, Gennex ensures consistent demand for its bulk drug offerings across domestic and international pharmaceutical markets. Gennex Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gennex Laboratories stock

On Eulerpool you can find the complete historical development of Goodwill Gennex Laboratories since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Gennex Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Gennex Laboratories

All Key Metrics — Gennex Laboratories